HCV Antiviral

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameHCV Antiviral

Drug Alias Nameantiviral (VLST)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsHepatitis C

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesVLST Corp

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesVLST Corp

Active IndicationsN/A

Inactive IndicationsHepatitis C

ATC CodeN/A